TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 6 | 9 | 22 | 36 | 103 | -17 | 27 |
| P | %wins | 100 | 100 | 100 | 100 | 100 | 0 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/16/18 19:45 | 5/14/18 | AQXP | Aquinox Pharmaceuticals, Inc | DE | Health | Drug | Pharmaceutical Preparations | Levitt Daniel J | A1 | D | M.d | 41 | 10.56 | 0 | 4 | 0 | D | ||||||||||||||||
5/16/18 19:45 | 5/14/18 | AQXP | Aquinox Pharmaceuticals, Inc | DE | Health | Drug | Pharmaceutical Preparations | Levitt Daniel J | A1 | D | S.d | -49 | 12.67 | 0 | -4 | -100 | 0 | D | |||||||||||||||
2/24/12 09:38 | 2/22/12 | CYTR | Cytrx Corp | DE | Health | BioPrd | Biological Products, (No Diag | Levitt Daniel J | CA | O | Chief Me | P | 29 | 0.2875 | 0 | 100 | New | 100 | D | -73 | -64 | -3 | -11 | 10 | 10 | -14 | 7 | 6 | 9 | 22 | 36 | 103 | -17 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |